X4 Pharmaceuticals, Inc.
NASDAQ:XFOR
0.8039 (USD) • At close December 27, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||
| Net Income
| -101.167 | -93.867 | -88.696 | -62.131 | -52.807 | -43.021 | -33.877 | -22.975 | -13.218 |
| Depreciation & Amortization
| 0.419 | 0.513 | 0.499 | 0.351 | 0.103 | 0.155 | 0.195 | 0.285 | 0.389 |
| Deferred Income Tax
| 0 | 0 | -6.679 | -5.779 | -2.153 | 0 | -0.269 | -1.392 | -0.001 |
| Stock Based Compensation
| 8.687 | 5.199 | 6.18 | 5.428 | 2.05 | 5.62 | 0.906 | 0.644 | 0.126 |
| Change In Working Capital
| 0.344 | 5.736 | -1.498 | -4.063 | -3.236 | -4.461 | 3.424 | -0.517 | 1.447 |
| Accounts Receivables
| 0 | -0.61 | 0 | 0 | 0 | -1.374 | -0.064 | 0.152 | -0.056 |
| Inventory
| 0 | 0.61 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 1.234 | 3.425 | 1.166 | 1.031 | -2.752 | -1.339 | 0.182 | 1.264 | 0.077 |
| Other Working Capital
| -0.89 | 2.311 | -2.664 | -5.094 | -0.484 | -3.122 | 3.242 | -1.781 | 1.37 |
| Other Non Cash Items
| -4.795 | 5.317 | 19.289 | 7.376 | 7.988 | 0.804 | 1.75 | 2.316 | 0.441 |
| Operating Cash Flow
| -96.512 | -77.102 | -70.905 | -58.818 | -48.055 | -40.903 | -27.871 | -21.639 | -10.816 |
| Investing Activities: | |||||||||
| Investments In Property Plant And Equipment
| -0.06 | -0.103 | -0.615 | -1.362 | -0.174 | -0.034 | -0.042 | -0.073 | -0.17 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 26.406 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -16.823 | -4.802 | 0 | 0 | 0 | 0 | 0 | -0.065 | -0.077 |
| Sales Maturities Of Investments
| 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 4.802 | 0 | 0 | 1 | 0 | 0.076 | -0.065 | -0.077 |
| Investing Cash Flow
| -14.883 | -0.103 | -0.615 | -1.362 | 27.232 | -0.034 | 0.034 | -0.138 | -0.247 |
| Financing Activities: | |||||||||
| Debt Repayment
| 20.436 | -0.795 | 0 | 12.388 | 0.481 | 2.402 | 3.279 | 12.764 | 4.501 |
| Common Stock Issued
| 59.999 | 122.631 | 75.985 | -0.277 | 139.388 | 4.468 | 66 | 5.5 | 7.016 |
| Common Stock Repurchased
| 0 | 0 | -2 | 0 | 0 | -1.126 | -0.197 | -0.087 | -0.012 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 8.081 | -4.606 | 0.26 | 0.283 | 0.792 | 4.468 | 31.983 | 5.383 | 7.004 |
| Financing Cash Flow
| 88.516 | 117.23 | 74.245 | 12.394 | 140.661 | -4.531 | 101.262 | 18.147 | 11.505 |
| Other Information: | |||||||||
| Effect Of Forex Changes On Cash
| 0.099 | -0.105 | -0.319 | 0.402 | -0.25 | -0.286 | 0.333 | -0.094 | -0.122 |
| Net Change In Cash
| -22.78 | 39.92 | 2.406 | -47.384 | 119.588 | -45.754 | 73.758 | -3.724 | 0.32 |
| Cash At End Of Period
| 100.248 | 123.028 | 83.108 | 80.702 | 128.086 | 31.394 | 76.793 | 3.035 | 6.759 |